middle.news
Lumos adds 50 FebriDx sites as US commercial momentum builds
9:59am on Tuesday 27th of October, 2026 AEDT
•
Healthcare
Read Story
Lumos adds 50 FebriDx sites as US commercial momentum builds
9:59am on Tuesday 27th of October, 2026 AEDT
Key Points
265 live FebriDx sites across 29 US states
485 additional sites in clinical and economic evaluation
Product revenue rises 224% to US$564,000
US$11.8 million cash and no debt at quarter end
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Lumos Diagnostics (ASX:LDX)
OPEN ARTICLE